Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Zhan JR"'
Autor:
Wang MQ; Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Chen YR; Department of Gastroenterology, Zhujiang Hospital of Southern Medical University, Guangzhou, China., Xu HW; Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Zhan JR; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Suo DQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Wang JJ; Department of radiotherapy, Sun Yat-sen University Cancer Center, Guangzhou, China., Ma YZ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Guan XY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Departments of Clinical Oncology, The University of Hong Kong, Hong Kong, China., Li Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Zhu SL; Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Publikováno v:
Cancer science [Cancer Sci] 2023 Apr; Vol. 114 (4), pp. 1365-1377. Date of Electronic Publication: 2023 Jan 02.
Autor:
Zeng TT; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China., Deng TH; The Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine, 410006, Changsha, China., Liu Z; Hunan Academy of Traditional Chinese Medicine, 410006, Changsha, China., Zhan JR; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China., Ma YZ; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China., Yan YY; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 510120, Guangzhou, China.; Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, 528200, Foshan, China., Sun X; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 510120, Guangzhou, China.; Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, 528200, Foshan, China., Zhu YH; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China., Li Y; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China., Guan XY; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China. xyguan@hku.hk.; Department of Clinical Oncology, Shenzhen Key Laboratory for Metastasis and Personalized Therapy, The University of Hong Kong-Shenzhen Hospital, 518053, Shenzhen, China. xyguan@hku.hk.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China. xyguan@hku.hk., Li L; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 510120, Guangzhou, China. lilei_728@163.com.; Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, 528200, Foshan, China. lilei_728@163.com.; Department of Clinical Oncology, Shenzhen Key Laboratory for Metastasis and Personalized Therapy, The University of Hong Kong-Shenzhen Hospital, 518053, Shenzhen, China. lilei_728@163.com.
Publikováno v:
Cell death & disease [Cell Death Dis] 2022 Dec 07; Vol. 13 (12), pp. 1026. Date of Electronic Publication: 2022 Dec 07.
Autor:
Shou C; State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, P.R. China., Zheng YC; State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, P.R. China., Zhan JR; State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, P.R. China., Li CX; State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, P.R. China., Xu JH; State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, P.R. China.
Publikováno v:
ChemSusChem [ChemSusChem] 2022 May 06; Vol. 15 (9), pp. e202101741. Date of Electronic Publication: 2021 Oct 13.
Autor:
Gerber PP; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Duncan LM; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Greenwood EJ; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Marelli S; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Naamati A; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Teixeira-Silva A; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Crozier TW; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Gabaev I; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Zhan JR; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Mulroney TE; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Horner EC; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Doffinger R; Department of Clinical Biochemistry and Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Willis AE; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Thaventhiran JE; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Protasio AV; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Matheson NJ; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.; NHS Blood and Transplant, Cambridge, United Kingdom.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2022 Feb 10; Vol. 18 (2), pp. e1010265. Date of Electronic Publication: 2022 Feb 10 (Print Publication: 2022).
Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection.
Autor:
Williams TL; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Colzani MT; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Macrae RGC; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Robinson EL; School of Medicine, Division of Cardiology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA., Bloor S; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Greenwood EJD; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Zhan JR; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Strachan G; Wellcome Trust-MRC Institute of Metabolic Science, Metabolic Research Laboratories, Addenbrooke's Biomedical Campus, Cambridge, UK., Kuc RE; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Nyimanu D; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Maguire JJ; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Lehner PJ; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Sinha S; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK. ss661@cam.ac.uk., Davenport AP; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. apd10@medschl.cam.ac.uk.
Publikováno v:
Communications biology [Commun Biol] 2021 Jul 29; Vol. 4 (1), pp. 926. Date of Electronic Publication: 2021 Jul 29.
Autor:
Chen QY; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Li YN; Westlake Institute for Advanced Study, Westlake University, Hangzhou, Zhejiang, P.R. China., Wang XY; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Zhang X; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Hu Y; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Li L; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Suo DQ; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Ni K; Westlake Institute for Advanced Study, Westlake University, Hangzhou, Zhejiang, P.R. China., Li Z; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Zhan JR; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Zeng TT; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Zhu YH; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Li Y; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Ma LJ; Westlake Institute for Advanced Study, Westlake University, Hangzhou, Zhejiang, P.R. China. xyguan@hku.hk malijia@westlake.edu.cn., Guan XY; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China. xyguan@hku.hk malijia@westlake.edu.cn.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, P.R. China.
Publikováno v:
Cancer research [Cancer Res] 2020 Dec 15; Vol. 80 (24), pp. 5583-5596. Date of Electronic Publication: 2020 Oct 22.
Autor:
Huangfu, Longtao1 (AUTHOR), Zhu, Huanbo1,2 (AUTHOR), Wang, Gangjian1,2 (AUTHOR), Chen, Junbing1,2 (AUTHOR), Wang, Yongqi1 (AUTHOR), Fan, Biao2 (AUTHOR), Wang, Xiaoyang3 (AUTHOR), Yao, Qian4 (AUTHOR), Guo, Ting1 (AUTHOR), Han, Jing1 (AUTHOR), Hu, Ying5 (AUTHOR), Du, Hong1 (AUTHOR), Li, Xiaomei1 (AUTHOR), Ji, Jiafu2,6 (AUTHOR) jijiafu@hsc.pku.edu.cn, Xing, Xiaofang6 (AUTHOR) xingxiaofang@bjmu.edu.cn
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 8/20/2024, Vol. 43 Issue 1, p1-15. 15p.
Publikováno v:
Journal of Cancer. 2024, Vol. 15 Issue 7, p1983-1993. 11p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xu, Rong1 (AUTHOR), Lee, Young-Joo1 (AUTHOR), Kim, Chang-Hyeon1 (AUTHOR), Min, Ga-Hong1 (AUTHOR), Kim, Yeo-Bin1 (AUTHOR), Park, Jung-Won1 (AUTHOR), Kim, Dae-Hoon1 (AUTHOR), Kim, Jung-Hyun2 (AUTHOR), Yim, Hyungshin1 (AUTHOR) hsyim@hanyang.ac.kr
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 11/16/2023, Vol. 42 Issue 1, p1-25. 25p.